ClinicalTrials.govpublic full text
Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer
ovarian neoplasms, advanced ovarian cancer, brca1 protein, brca2 protein, poly(adp ribose) polymerases, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 902693
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.